239 related articles for article (PubMed ID: 33726696)
1. Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy.
Fang R; Wang H; Li Y; Liu YM; Wei WB
BMC Ophthalmol; 2021 Mar; 21(1):137. PubMed ID: 33726696
[TBL] [Abstract][Full Text] [Related]
2. Regression rate of posterior uveal melanomas following iodine-125 plaque radiotherapy.
Demirci H; Saponara F; Khan A; Niziol LM; Lee C; Hayman JA; Comer G; Musch DC
Middle East Afr J Ophthalmol; 2015; 22(1):103-7. PubMed ID: 25624683
[TBL] [Abstract][Full Text] [Related]
3. Association between Tumor Regression Rate and Gene Expression Profile after Iodine 125 Plaque Radiotherapy for Uveal Melanoma.
Mruthyunjaya P; Seider MI; Stinnett S; Schefler A;
Ophthalmology; 2017 Oct; 124(10):1532-1539. PubMed ID: 28549517
[TBL] [Abstract][Full Text] [Related]
4. [The clinical observation of external scleral plaque radiotherapy in patients with uveal melanoma].
Liu YM; Zhou N; Wei WB; Wang P
Zhonghua Yan Ke Za Zhi; 2020 Sep; 56(9):670-675. PubMed ID: 32907299
[No Abstract] [Full Text] [Related]
5. Scleral necrosis in patients with posterior uveal melanomas evaluated by transcleral fine needle aspiration biopsy and treated by 125I plaque.
Correa ZM; Huth B; Augsburger JJ
Arq Bras Oftalmol; 2018; 81(4):330-335. PubMed ID: 29995126
[TBL] [Abstract][Full Text] [Related]
6. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
7. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
Toivonen P; Kivelä T
Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling and regression rate of irradiated uveal melanomas.
Rao RC; Khan M; Badiyan SN; Harbour JW
Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):333-7. PubMed ID: 25856819
[TBL] [Abstract][Full Text] [Related]
9. Iodine 125 plaque brachytherapy versus transscleral tumor resection in the treatment of large uveal melanomas.
Bechrakis NE; Bornfeld N; Zöller I; Foerster MH
Ophthalmology; 2002 Oct; 109(10):1855-61. PubMed ID: 12359606
[TBL] [Abstract][Full Text] [Related]
10. Palladium 103 plaque radiotherapy for uveal melanoma. Clinical experience.
Finger PT; Buffa A; Mishra S; Berson A; Bosworth JL; Vikram B
Ophthalmology; 1994 Feb; 101(2):256-63. PubMed ID: 8115147
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy.
Wang H; Zhang R; Wang Y; Chen R; Liu Y; Li Y; Wei W
BMC Ophthalmol; 2022 Apr; 22(1):163. PubMed ID: 35397506
[TBL] [Abstract][Full Text] [Related]
12. Regression of uveal melanoma after ru-106 brachytherapy and thermotherapy based on metabolic activity measured by positron emission tomography/computed tomography.
Lee CS; Lee SC; Lee K; Kwon HJ; Yi JH; Cho A
Retina; 2014 Jan; 34(1):182-7. PubMed ID: 23719400
[TBL] [Abstract][Full Text] [Related]
13. Tumor-height regression rate after brachytherapy between choroidal melanoma gene expression profile classes: effect of controlling for tumor height.
Gupta K; McCannel CA; Kamrava M; Lamb J; Almanzor RD; McCannel TA
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1371-8. PubMed ID: 26907932
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy.
Badiyan SN; Rao RC; Apicelli AJ; Acharya S; Verma V; Garsa AA; DeWees T; Speirs CK; Garcia-Ramirez J; Esthappan J; Grigsby PW; Harbour JW
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):801-5. PubMed ID: 24462385
[TBL] [Abstract][Full Text] [Related]
15. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.
Nag S; Quivey JM; Earle JD; Followill D; Fontanesi J; Finger PT;
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):544-55. PubMed ID: 12738332
[TBL] [Abstract][Full Text] [Related]
16. Regression of posterior uveal melanomas following cobalt-60 plaque radiotherapy.
Cruess AF; Augsburger JJ; Shields JA; Brady LW; Markoe AM; Day JL
Ophthalmology; 1984 Dec; 91(12):1716-9. PubMed ID: 6522001
[TBL] [Abstract][Full Text] [Related]
17. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
Puusaari I; Heikkonen J; Kivelä T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
[TBL] [Abstract][Full Text] [Related]
18. 125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control.
Quivey JM; Augsburger J; Snelling L; Brady LW
Cancer; 1996 Jun; 77(11):2356-62. PubMed ID: 8635107
[TBL] [Abstract][Full Text] [Related]
19. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients.
Shields CL; Shields JA; Cater J; Gündüz K; Miyamoto C; Micaily B; Brady LW
Arch Ophthalmol; 2000 Sep; 118(9):1219-28. PubMed ID: 10980767
[TBL] [Abstract][Full Text] [Related]
20. Vision Loss Following Episcleral Brachytherapy for Uveal Melanoma: Development of a Vision Prognostication Tool.
Aziz HA; Singh N; Bena J; Wilkinson A; Singh AD
JAMA Ophthalmol; 2016 Jun; 134(6):615-20. PubMed ID: 27101414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
